&nbsp;

YVM_FAQ_Staff-FR.docx

Sep 2021

Document

YVMSurvey_Inperson_Print.docx

Sep 2021

Document

YVMSurvey_Inperson_Print-FR.docx

Sep 2021

Document

YVMSurvey_televid_Print.docx

Sep 2021

Document

YVMSurvey_televid_Print-FR.docx

Sep 2021

Document

CCOPEBCConflictInterestPolicy.pdf

Oct 2021

Regimen

CRBPPACL

Cancer Type:

Gynecologic,

Vulva

Intent: Palliative

Drugs Used:

PACLitaxel,

CARBOplatin

Quick Link(s):

Regimen Monograph, Patient Info Sheet (Every 3 weeks)

Oct 2021

Regimen

CAPM

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

capmatinib (Unfunded)

Quick Link(s):

Regimen Monograph

Oct 2021

Regimen

CARFCYCLDEXA

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

carfilzomib (Unfunded),

cyclophosphamide,

dexamethasone

Quick Link(s):

Regimen Monograph

Oct 2023

Regimen

CRBPPEME

Cancer Type:

Gastrointestinal

Intent: Palliative

Drugs Used:

pemetrexed,

CARBOplatin

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Nov 2021

Regimen

CRBPGEMC(W)+PEMB

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Locally Recurrent Unresectable or Metastatic Triple Negative Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2023

Regimen

CRBPPACL(W)

Cancer Type:

Breast

Intent: Neoadjuvant

Drugs Used:

PACLitaxel,

CARBOplatin